1h Free Analyst Time
The publisher has been monitoring the anti-inflammatory therapeutics market and it is poised to grow by $32.70 bn during 2021-2025, progressing at a CAGR of over 6% during the forecast period. The report on anti-inflammatory therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in prevalence of IMID and availability of targeted therapy.
The anti-inflammatory therapeutics market analysis includes application segment and geographic landscape.
The anti-inflammatory therapeutics market is segmented as below:
By Application
- RA
- Psoriasis
- MS
By Geography
- North America
- Europe
- Asia
- ROW
This study identifies the increase in off-label use as one of the prime reasons driving the anti-inflammatory therapeutics market growth during the next few years.
The report on anti-inflammatory therapeutics market covers the following areas:
- Anti-inflammatory therapeutics market sizing
- Anti-inflammatory therapeutics market forecast
- Anti-inflammatory therapeutics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-inflammatory therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Novartis AG, and Pfizer Inc. Also, the anti-inflammatory therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Application
Market Segmentation by Drug Class
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global anti-inflammatory therapeutics market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Novartis AG, and Pfizer Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the increase in off-label use.'
According to the report, one of the major drivers for this market is the increase in prevalence of IMID.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson and Johnson
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.